9 results on '"Mazimba, Sula"'
Search Results
2. Update on Current Management of Atrial Fibrillation.
- Author
-
Mazimba, Sula, Anaya-Cisneros, Maurico, and Parikh, Analkumar
- Subjects
- *
ANTICOAGULANTS , *ATRIAL fibrillation diagnosis , *ATRIAL fibrillation prevention , *ATRIAL fibrillation risk factors , *CEREBROVASCULAR disease risk factors , *HEART disease diagnosis , *THROMBOEMBOLISM risk factors , *HEART ventricle diseases , *MYOCARDIAL depressants , *AGE distribution , *ATRIAL fibrillation , *ECHOCARDIOGRAPHY , *LEFT heart ventricle diseases , *HEART beat , *IMPLANTABLE cardioverter-defibrillators , *MEDICAL needs assessment , *PRIMARY health care , *SEX distribution , *LIFESTYLES , *CONTINUING education units , *DISEASE prevalence , *SEVERITY of illness index , *ABLATION techniques , *SYMPTOMS , *DIAGNOSIS , *THERAPEUTICS ,CHRONIC disease diagnosis - Abstract
The article offers updates on atrial fibrillation (AF) management. It reviews the classification of AF, the epidemiology, etiology, symptoms and manifestations and the strategic objectives in AF management involving rhythm control, rate control and thromboembolism prevention that can be achieved through non-pharmacological and pharmacological means. It also notes oral anticoagulant therapy, antiarrhythmic drugs, pacemaker therapy and implantable atrial defibrillators.
- Published
- 2011
3. Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies.
- Author
-
Kalathoor S, Ghazi S, Otieno B, Babcook MA, Chen S, Nidhi N, Bae J, Pierre-Charles J, Breathett K, Mazimba S, Johnson A, Brewer L, Mohammed S, Carter RR, Bonsu JM, Ferdousi M, Kola-Kehinde O, McLaughlin E, Brammer J, Ruz P, Khan S, Odei B, Mitchell D, Wei L, Patel P, Paskett ED, and Addison D
- Subjects
- Humans, Female, United States epidemiology, Male, Middle Aged, Clinical Trials as Topic, Aged, Clinical Trials, Phase II as Topic, Patient Selection, Neoplasms drug therapy, Neoplasms epidemiology, Drug Approval, Antineoplastic Agents therapeutic use, United States Food and Drug Administration
- Abstract
Contemporary anticancer therapies frequently have different efficacy and side effects in men and women. Yet, whether women are well-represented in pivotal trials supporting contemporary anticancer drugs is unknown. Leveraging the Drugs@FDA database, clinicaltrials.gov, MEDLINE, and publicly available FDA-drug-reviews, we identified all pivotal (phase II and III) non-sex specific trials supporting FDA-approval of anticancer drugs (1998-2018). Observed-enrollment-rates were compared to expected-population-rates derived from concurrent US-National-Cancer-Institute's Surveillance-Epidemiology-and-End-Results (SEER) reported rates and US-Census databases. Primary outcome was the proportional representation of women across trials, evaluated by a participation-to-prevalence ratio (PPR), according to cancer type. Secondary outcome was the report of any sex-specific analysis of efficacy and/or safety, irrespective of treatment-arm. Overall, there were 148 trials, enrolling 60,216 participants (60.5 ± 4.0 years, 40.7% female, 79.1% biologic, targeted, or immune-based therapies) evaluating 99 drugs. Sex was reported in 146 (98.6%) trials, wherein 40.7% (24,538) were women, compared to 59.3% (35,678) men (p < .01). Altogether, women were under-represented in 66.9% trials compared to the proportional incidence of cancers by respective disease type; weight-average PPR of 0.91 (relative difference: -9.1%, p < .01). Women were most under-represented in gastric (PPR = 0.63), liver (PPR = 0.71), and lung (PPR = .81) cancer trials. Sex-based safety data was reported in 4.0% trials. There was no association between adequate female enrollment and drug efficacy (HR: 0.616 vs. 0.613, p = .96). Over time, there was no difference in the percentage of women recruited into clinical trials. Among pivotal clinical trials supporting contemporary FDA-approved cancer drugs, women were frequently under-represented and sex-specific-efficacy and safety-outcomes were commonly not reported., (© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.)
- Published
- 2024
- Full Text
- View/download PDF
4. Differences in Donor Heart Acceptance by Race and Gender of Patients on the Transplant Waiting List.
- Author
-
Breathett K, Knapp SM, Lewsey SC, Mohammed SF, Mazimba S, Dunlay SM, Hicks A, Ilonze OJ, Morris AA, Tedford RJ, Colvin MM, and Daly RC
- Subjects
- Adult, Female, Humans, Male, Cohort Studies, Sex Factors, Tissue Donors statistics & numerical data, United States epidemiology, Waiting Lists, Race Factors, Health Services Accessibility statistics & numerical data, Black or African American statistics & numerical data, Heart Transplantation statistics & numerical data, Tissue and Organ Procurement statistics & numerical data, White People statistics & numerical data, Healthcare Disparities ethnology, Healthcare Disparities statistics & numerical data, Heart Failure epidemiology, Heart Failure ethnology, Heart Failure surgery
- Abstract
Importance: Barriers to heart transplant must be overcome prior to listing. It is unclear why Black men and women remain less likely to receive a heart transplant after listing than White men and women., Objective: To evaluate whether race or gender of a heart transplant candidate (ie, patient on the transplant waiting list) is associated with the probability of a donor heart being accepted by the transplant center team with each offer., Design, Setting, and Participants: This cohort study used the United Network for Organ Sharing datasets to identify organ acceptance with each offer for US non-Hispanic Black (hereafter, Black) and non-Hispanic White (hereafter, White) adults listed for heart transplant from October 18, 2018, through March 31, 2023., Exposures: Black or White race and gender (men, women) of a heart transplant candidate., Main Outcomes and Measures: The main outcome was heart offer acceptance by the transplant center team. The number of offers to acceptance was assessed using discrete time-to-event analyses, nonparametrically (stratified by race and gender) and parametrically. The hazard probability of offer acceptance for each offer was modeled using generalized linear mixed models adjusted for candidate-, donor-, and offer-level variables., Results: Among 159 177 heart offers with 13 760 donors, there were 14 890 candidates listed for heart transplant; 30.9% were Black, 69.1% were White, 73.6% were men, and 26.4% were women. The cumulative incidence of offer acceptance was highest for White women followed by Black women, White men, and Black men (P < .001). Odds of acceptance were less for Black candidates than for White candidates for the first offer (odds ratio [OR], 0.76; 95% CI, 0.69-0.84) through the 16th offer. Odds of acceptance were higher for women than for men for the first offer (OR, 1.53; 95% CI, 1.39-1.68) through the sixth offer and were lower for the 10th through 31st offers., Conclusions and Relevance: The cumulative incidence of heart offer acceptance by a transplant center team was consistently lower for Black candidates than for White candidates of the same gender and higher for women than for men. These disparities persisted after adjusting for candidate-, donor-, and offer-level variables, possibly suggesting racial and gender bias in the decision-making process. Further investigation of site-level decision-making may reveal strategies for equitable donor heart acceptance.
- Published
- 2024
- Full Text
- View/download PDF
5. Association Between the Affordable Care Act Medicaid Expansion and Receipt of Cardiac Resynchronization Therapy by Race and Ethnicity.
- Author
-
Mwansa H, Barry I, Knapp SM, Mazimba S, Calhoun E, Sweitzer NK, and Breathett K
- Subjects
- Ethnicity, Hispanic or Latino, Humans, Insurance Coverage, Medicaid, United States epidemiology, Cardiac Resynchronization Therapy, Patient Protection and Affordable Care Act
- Abstract
Background Black and Hispanic patients are less likely to receive cardiac resynchronization therapy (CRT) than White patients. Medicaid expansion has been associated with increased access to cardiovascular care among racial and ethnic groups with higher prevalence of underinsurance. It is unknown whether the Medicaid expansion was associated with increased receipt of CRT by race and ethnicity. Methods and Results Using Healthcare Cost and Utilization Project Data State Inpatient Databases from 19 states and Washington, DC, we analyzed 1061 patients from early-adopter states (Medicaid expansion by January 2014) and 745 patients from nonadopter states (no implementation 2013-2014). Estimates of change in census-adjusted rates of CRT with or without defibrillator by race and ethnicity and Medicaid adopter status 1 year before and after January 2014 were conducted using a quasi-Poisson regression model. Following the Medicaid expansion, the rate of CRT did not significantly change among Black individuals from early-adopter states (1.07 [95% CI, 0.78-1.48]) or nonadopter states (0.79 [95% CI, 0.57-1.09]). There were no significant changes in rates of CRT among Hispanic individuals from early-adopter states (0.99 [95% CI, 0.70-1.38]) or nonadopter states (1.01 [95% CI, 0.65-1.57]). There was a 34% increase in CRT rates among White individuals from early-adopter states (1.34 [95% CI, 1.05-1.70]), and no significant change among White individuals from nonadopter states (0.77 [95% CI, 0.59-1.02]). The change in CRT rates among White individuals was associated with the timing of the Medicaid implementation ( P =0.003). Conclusions Among states participating in Healthcare Cost and Utilization Project Data State Inpatient Databases, implementation of Medicaid expansion was associated with increase in CRT rates among White individuals residing in states that adopted the Medicaid expansion policy. Further work is needed to address disparities in CRT among Black and Hispanic patients.
- Published
- 2022
- Full Text
- View/download PDF
6. Is the Affordable Care Act Medicaid Expansion Linked to Change in Rate of Ventricular Assist Device Implantation for Blacks and Whites?
- Author
-
Breathett KK, Knapp SM, Wightman P, Desai A, Mazimba S, Calhoun E, and Sweitzer NK
- Subjects
- Adult, Aged, Databases, Factual, Eligibility Determination trends, Female, Heart Failure diagnosis, Heart Failure epidemiology, Heart Failure physiopathology, Humans, Male, Middle Aged, Practice Patterns, Physicians' trends, Prosthesis Implantation adverse effects, Prosthesis Implantation instrumentation, Time Factors, Treatment Outcome, United States epidemiology, Ventricular Function, Young Adult, Black or African American, Healthcare Disparities trends, Heart Failure therapy, Heart-Assist Devices trends, Medicaid trends, Outcome and Process Assessment, Health Care trends, Patient Protection and Affordable Care Act trends, Prosthesis Implantation trends, White People
- Abstract
Background: The Affordable Care Act (ACA) has been associated with increased heart transplant listings among blacks, who are disproportionately uninsured. It is unclear whether the ACA is also associated with increased ventricular assist device implantation in blacks., Methods: Using Healthcare Cost and Utilization Project Data State Inpatient Databases from 19 states and Washington DC, we analyzed 1157 patients from early-adopter states (ACA Medicaid expansion by January 2014) and 785 patients from nonadopter states (no implementation from 2013 to 2014). Piecewise Poisson regression with a discontinuity was used to estimate change in census-adjusted rates of ventricular assist device implants by race and ACA adopter status 1 year before and after January 2014., Results: Following the ACA Medicaid expansion, the proportional change in rate increased significantly among blacks from early adopter (1.40 [95% CI, 1.12-1.75], pre 0.57/100 000 to post-ACA 0.80/100 000) but not nonadopter states (1.25 [95% CI, 0.98-1.58], pre 0.40/100 000 to post-ACA 0.50/100 000). However, the early and nonadopter changes in implantation rates were not statistically different from each other ( P =0.50). There were no immediate changes in whites in either state group following the ACA Medicaid expansion (early adopter, 1.12 [95% CI, 0.98-1.29], pre 0.27/100 000 to post-ACA 0.30/100 000; nonadopter, 0.98 [95% CI, 0.82-1.16], pre 0.27/100 000 to post-ACA 0.26/100 000)., Conclusions: Among eligible states participating in Healthcare Cost and Utilization Project Data State Inpatient Databases, the ACA was not associated with immediate changes in ventricular assist device implantation rates by race. Although a significant increase in implantation rate was observed among blacks from early-adopter states, the change was not statistically different from the change seen in nonadopter states.
- Published
- 2020
- Full Text
- View/download PDF
7. Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
- Author
-
Mazimba S, Welch TS, Mwansa H, Breathett KK, Kennedy JLW, Mihalek AD, Harding WC, Mysore MM, Zhuo DX, and Bilchick KC
- Subjects
- Adult, Echocardiography, Female, Hemodynamics, Humans, Hypertension, Pulmonary diagnosis, Hypertension, Pulmonary mortality, Male, Middle Aged, Prognosis, Pulmonary Artery diagnostic imaging, ROC Curve, Risk Factors, Survival Rate trends, United States epidemiology, Young Adult, Hypertension, Pulmonary physiopathology, Pulmonary Artery physiopathology, Pulmonary Wedge Pressure physiology, Pulsatile Flow physiology, Registries
- Abstract
Background: Pulmonary artery (PA) pulsitility index (PAPi) is a novel haemodynamic index shown to predict right ventricular failure in acute inferior myocardial infarction and post left ventricular assist device surgery. We hypothesised that PAPi calculated as [PA systolic pressure - PA diastolic pressure]/right atrial pressure (RAP) would be associated with mortality in the National Institutes of Health Registry for Primary Pulmonary Hypertension (NIH-RPPH)., Methods: The impact of PAPi, the Pulmonary Hypertension Connection (PHC) risk score, right ventricular stroke work, pulmonary artery capacitance (PAC), other haemodynamic indices, and demographic characteristics was evaluated in 272 NIH-RPPH patients using multivariable Cox proportional hazards (CPH) regression and receiver operating characteristic (ROC) analysis., Results: In the 272 patients (median age 37.7+/-15.9years, 63% female), the median PAPi was 5.8 (IQR 3.7-9.2). During 5years of follow-up, 51.8% of the patients died. Survival was markedly lower (32.8% during the first 3years) in PAPi quartile 1 compared with the remaining patients (58.5% over 3years in quartiles 2-4; p<0.0001). The best multivariable CPH survival model included PAPi, the PHC-Risk score, PAC, and body mass index (BMI). In this model, the adjusted hazard ratio for death with increasing PAPi was 0.946 (95% CI 0.905-0.989). The independent ROC areas for 5-year survival based on bivariable logistic regression for PAPi, BMI, PHC Risk, and PAC were 0.63, 0.62, 0.64, and 0.65, respectively (p<0.01). The ROC area for 5-year survival for the multivariable logistic model with all four covariates was 0.77 (p<0.0001)., Conclusions: Pulmonary artery pulsatility index was independently associated with survival in PAH, highlighting the utility of PAPi in combination with other key measures for risk stratification in this population., (Copyright © 2018 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
8. Temporal Trends in Contemporary Use of Ventricular Assist Devices by Race and Ethnicity.
- Author
-
Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Blair IV, Jones J, Khazanie P, Mazimba S, McEwen M, Stone J, Calhoun E, Sweitzer NK, and Peterson PN
- Subjects
- Adult, Age Factors, Aged, Asian, Female, Heart Failure diagnosis, Heart Failure physiopathology, Hispanic or Latino, Humans, Male, Middle Aged, Prosthesis Design, Registries, Sex Factors, Time Factors, United States, White People, Young Adult, Black or African American, Healthcare Disparities trends, Heart Failure ethnology, Heart Failure therapy, Heart-Assist Devices trends, Practice Patterns, Physicians' trends, Ventricular Function
- Abstract
Background: The proportion of racial/ethnic minorities receiving ventricular assist devices (VADs) has previously been less than expected. It is unclear if trends have changed since the broadening of access to insurance in 2014 and the rapid adoption of VAD technology., Methods and Results: Using the Interagency Registry of Mechanically Assisted Circulatory Support, we analyzed time trends by race/ethnicity for 10 795 patients (white, 67.4%; African-American, 24.8%; Hispanic, 6.3%; Asian, 1.5%) who had a VAD implanted between 2012 and 2015. Linear models were fit to the annual census-adjusted rate of VAD implantation for each racial/ethnic group, stratified by sex and age group. From 2012 to 2015, African-Americans had an increase in the census-adjusted annual rate of VAD implantation per 100 000 (0.26 [95% confidence interval, 0.17-0.34]) while other ethnic groups exhibited no significant changes (white: 0.06 [-0.03 to 0.14]; Hispanic: 0.04 [-0.05 to 0.12]; Asian: 0.04 [-0.04 to 0.13]). Stratified by sex, rates increased in both African-American men and women ( P <0.05), but the change in rate was highest among African-American men (men 0.37 [0.28-0.46]; women 0.16 [0.07-0.25]; interaction with sex P =0.004). Stratified by age group, rates increased in African-Americans aged 40 to 69 years and Asians aged 50 to 59 years ( P <0.05). The observed differential change in VAD implantation rate by age group was significant among African-Americans (interaction with age, P <0.01) and Asians (interaction with age, P =0.02)., Conclusions: From 2012 to 2015, VAD implantation rates increased among African-Americans but not other racial/ethnic groups. The greatest increase in rate was observed among middle-aged African-American men, suggesting a decline in racial disparities. Further investigation is warranted to reduce disparities among women and older racial/ethnic minorities., (© 2018 American Heart Association, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
9. African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure.
- Author
-
Breathett K, Liu WG, Allen LA, Daugherty SL, Blair IV, Jones J, Grunwald GK, Moss M, Kiser TH, Burnham E, Vandivier RW, Clark BJ, Lewis EF, Mazimba S, Battaglia C, Ho PM, and Peterson PN
- Subjects
- Black or African American ethnology, Aged, Female, Healthcare Disparities ethnology, Heart Failure, Diastolic ethnology, Heart Failure, Diastolic mortality, Heart Failure, Systolic ethnology, Heart Failure, Systolic mortality, Hospital Mortality, Hospitalization statistics & numerical data, Hospitals, Rural statistics & numerical data, Hospitals, Urban statistics & numerical data, Humans, Intensive Care Units statistics & numerical data, Male, Middle Aged, Retrospective Studies, United States epidemiology, Black or African American statistics & numerical data, Cardiologists statistics & numerical data, Critical Care statistics & numerical data, Heart Failure, Diastolic therapy, Heart Failure, Systolic therapy
- Abstract
Objectives: This study sought to determine whether the likelihood of receiving primary intensive care unit (ICU) care by a cardiologist versus a noncardiologist was greater for Caucasians than for African Americans admitted to an ICU for heart failure (HF). The authors further evaluated whether primary ICU care by a cardiologist is associated with higher in-hospital survival, irrespective of race., Background: Increasing data demonstrate an association between better HF outcomes and care by a cardiologist. It is unclear if previously noted racial differences in cardiology care persist in an ICU setting., Methods: Using the Premier database, adult patients admitted to an ICU with a primary discharge diagnosis of HF from 2010 to 2014 were included. Hierarchical logistic regression models were used to determine the association between race and primary ICU care by a cardiologist, adjusting for patient and hospital variables. Cox regression with inverse probability weighting was used to assess the association between cardiology care and in-hospital mortality., Results: Among 104,835 patients (80.3% Caucasians, 19.7% African Americans), Caucasians had higher odds of care by a cardiologist than African Americans (adjusted odds ratio: 1.42; 95% confidence interval: 1.34 to 1.51). Compared with a noncardiologist, primary ICU care by a cardiologist was associated with higher in-hospital survival (adjusted hazard ratio: 1.20, 95% confidence interval: 1.11 to 1.28). The higher likelihood of survival did not differ by patient race (interaction p = 0.32)., Conclusions: Among patients admitted to an ICU for HF, African Americans were less likely than Caucasians to receive primary care by a cardiologist. Primary care by a cardiologist was associated with higher survival for both Caucasians and African Americans., (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.